The Biggest Issue with Treatment of Breast Cancer in Men
Fatima Cardoso, MD, medical oncologist at the Champalimaud Clinical Centre in Portugal, explains the biggest issue in treatment of male breast cancer is due to lack of education. Male patients are most commonly diagnosed in the advanced stages because of this and are commonly given the wrong treatments, says Cardoso.
Fatima Cardoso, MD, medical oncologist at the Champalimaud Clinical Centre in Portugal, explains the biggest issue in treatment of male breast cancer is due to lack of education. Male patients are most commonly diagnosed in the advanced stages because of this and are commonly given the wrong treatments, says Cardoso.
Men with breast cancer have a lesser quality of care than women with breast cancer since there is a widespread of uncertainty amongst physicians in the field. Almost every case of male breast cancer is estrogen receptor-positive (ER), but most men are not being treated properly. According to Cardoso, only 70% of men with ER-positive breast cancer are being treated with endocrine therapy, leaving a large number of patients without the right treatment.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
Acalabrutinib/Obinutuzumab Shows Improved PFS in Treatment-Naive CLL
April 10th 2024In an interview with Targeted Oncology, Jeff Sharman, MD, discussed the results of the ELEVATE-TN trial of acalabrutinib with or without obinutuzumab at 74.5 months of follow-up among patients with chronic lymphocytic leukemia.
Read More
